Long‐Term Outcomes and Risk Factors for Mortality After Single Ventricle Palliation for Asplenia Syndrome
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.044756 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Yasuyuki Kobayashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences and Okayama University Ho…. Hauptthemen laut MEDLINE: Heterotaxy Syndrome, Palliative Care, Heart Ventricles. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
This study evaluated the long‐term outcomes of asplenia syndrome with single ventricle palliation, hypothesizing that total anomalous pulmonary vein connection (TAPVC), pulmonary atresia (PA), and greater than or equal to moderate atrioventricular valve regurgitation increase mortality risk.
Methods
This retrospective review analyzed 151 patients with asplenia syndrome who underwent single ventricle palliation between 1990 and 2024. The primary end point was mortality, with risk factors assessed by Cox regression analysis over a mean follow‐up of 9.3 years.
Results
The median age at initial operation was 35 days, including 70 neonates (46%). Overall, 62 (41%) patients died, whereas 66 (44%) patients are alive post‐Fontan completion. Survival probabilities at 1 and 20 years were 75.7% (95% CI, 67.9–81.8) and 53.7% (95% CI, 44.5–62.0), respectively. TAPVC ( P =0.014), PA ( P =0.007), and greater than or equal to moderate atrioventricular valve regurgitation ( P =0.040) emerged as independent risk factors for mortality in the overall cohort. In the TAPVC cohort, independent risk factors for mortality included PA ( P =0.019), infracardiac TAPVC ( P =0.045), and neonatal TAPVC repair ( P =0.018). When stratified by the risk factors of TAPVC, PA, or greater than or equal to moderate atrioventricular valve regurgitation, survival probabilities did not differ between patients with none or 1 of these conditions ( P =0.181) but were significantly lower in those with ≥2 risk factors ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences and Okayama University Hospital Okayama Japan.
- Department of Pediatric Cardiac Surgery Showa Medical University Toyosu Hospital Tokyo Japan.
- Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston Harvard Medical School Boston MA USA.
ORCID-Profile: Yasuyuki Kobayashi, Shunji Sano, Yuhei Tokuda, Ayari Kimura, Steven J Staffa, David Zurakowski, Shingo Kasahara, Yasuhiro Kotani
Zitieren
APA
Kobayashi, Y., Sano, S., Tokuda, Y., Kimura, A., Staffa, S. J., Zurakowski, D., Kasahara, S., & Kotani, Y. (2026). Long‐Term Outcomes and Risk Factors for Mortality After Single Ventricle Palliation for Asplenia Syndrome. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.044756
Vancouver
Kobayashi Y, Sano S, Tokuda Y, Kimura A, Staffa SJ, Zurakowski D, et al. Long‐Term Outcomes and Risk Factors for Mortality After Single Ventricle Palliation for Asplenia Syndrome. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.044756
BibTeX
@article{Kobayashi2026,
author = {Kobayashi, Yasuyuki and Sano, Shunji and Tokuda, Yuhei and Kimura, Ayari and Staffa, Steven J and Zurakowski, David and Kasahara, Shingo and Kotani, Yasuhiro},
title = {Long‐Term Outcomes and Risk Factors for Mortality After Single Ventricle Palliation for Asplenia Syndrome},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.044756}
}
EUVIMED